What are the typical presentations of labia (vulvar) cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Presentation of Vulvar Cancer

Vulvar cancer most commonly presents as a single mass or ulcer on the labia majora or minora, often accompanied by pruritus, pain, irritation, and sometimes bleeding or discharge. 1

Common Presenting Features

Primary Symptoms

  • Pruritus (itching) - most common symptom
  • Pain or irritation
  • Vulvar bleeding or discharge
  • Asymptomatic in some cases 1

Physical Findings

  • Single mass or ulcer (most common presentation in HPV-negative tumors)
  • Multifocal lesions (more common in HPV-positive tumors)
  • Location distribution:
    • Labia majora (most common site)
    • Labia minora
    • Clitoris
    • Mons pubis
    • Perineum 1

Appearance Variations

The appearance of vulvar cancer can vary considerably:

  • Nodular growth
  • Ulcerative lesion
  • Raised plaque
  • Pigmented lesion (in melanoma cases)
  • Porcelain-white papules/plaques (if arising from lichen sclerosus) 2

Risk Factors and Associated Findings

  • HPV infection (especially high-risk strains HPV-16 and HPV-18) - present in up to 69% of cases 1
  • Concurrent cervical neoplasia (more common in HPV-positive tumors) 1
  • Advanced age (most common in postmenopausal women) 3
  • Chronic inflammation of the vulva
  • Smoking
  • Immunocompromised state 1

Diagnostic Approach

When vulvar cancer is suspected:

  1. Perform careful visual examination assessing color, size, distribution, and associated findings (ulceration, bleeding)
  2. Palpate to evaluate consistency, tenderness, mobility, and depth
  3. Check for inguinal lymphadenopathy (though clinical palpation has high false-negative rate) 1, 2
  4. Obtain biopsy of suspicious areas for definitive diagnosis 1
  5. Consider imaging (MRI, CT, PET/CT) for larger tumors (T2 or greater) or if metastasis is suspected 1

Important Considerations

  • Most patients present with early-stage (localized) disease 1
  • Lymph node status is the most important prognostic factor in vulvar cancer 1
  • The 5-year survival rate is 86% for vulvar-confined disease but drops to 57% with regional lymph node metastases 1
  • Squamous cell carcinoma accounts for 90% of vulvar cancers 1
  • Less common types include basal cell carcinoma (less than 5% of vulvar neoplasms) 4 and melanoma 5

Pitfalls in Diagnosis

  • Misattribution of symptoms to hemorrhoids, leading to delayed diagnosis 1
  • Confusion with benign conditions like Bartholin gland cysts, lichen sclerosus, or keratoacanthoma 2, 6
  • Inadequate biopsy technique (need to include underlying stroma and avoid necrotic areas) 1
  • Failure to examine the vagina and cervix for concurrent neoplasia 1

Early recognition and prompt biopsy of suspicious vulvar lesions are essential for timely diagnosis and improved outcomes, particularly in older women presenting with persistent vulvar symptoms.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vulvar Nodules Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cancer of the vulva: 2021 update.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2021

Research

[Malignant melanomas of the vulva].

Deutsche medizinische Wochenschrift (1946), 1985

Research

Keratoacanthoma of the vulva.

Gynecologic oncology, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.